XML 40 R28.htm IDEA: XBRL DOCUMENT
v3.26.1

Summary of Significant Accounting Policies (Details Narrative) - USD ($) | 3 Months Ended
--- | ---
Mar. 31, 2026 | Mar. 31, 2025
Product Information [Line Items] |  |
Impairment of long lived assets | $ 0 | $ 0
Legal Fees | $ 35,032 | $ 56,084
Foreign currency rate | 1.1703 | 1.0516
Cost Of Sale [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage | 10.00% | 10.00%
General And Administrative Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Other Vendor And Consultant [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage | 2.70% | 9.10%
General And Administrative Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Vendor [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage | 7.29% | 30.00%
General And Administrative Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | One Vendor and Consultant [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage | 20.00% |
General And Administrative Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Directors And Corporate Officers [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage | 0.00% | 12.10%
Research And Development Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Two Vendor [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage | 90.60% |
Research And Development Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant One [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage |  | 30.70%
Research And Development Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant Two [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage |  | 17.10%
Research And Development Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant Three [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage |  | 15.30%
Research And Development Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant Four [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage |  | 15.10%
Research And Development Expenses [Member] | Cost Of Sale [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant Five [Member] |  |
Product Information [Line Items] |  |
Concentration risk, percentage |  | 14.70%

X
- Definition Foreign currency exchange rate translation. + References No definition available. + Details
Name: | LIXT_ForeignCurrencyExchangeRateTranslation
Namespace Prefix: | LIXT_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(6)) -SubTopic 10 -Topic 220 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_LegalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ProductInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | LIXT_StatementOfIncomeLocationBalancesAxis=LIXT_CostOfSaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | LIXT_StatementOfIncomeLocationBalancesAxis=LIXT_GeneralAndAdministrativeExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=LIXT_CostOfSaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_OtherVendorAndConsultantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_VendorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_OneVendorAndConsultantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_DirectorsAndCorporateOfficersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | LIXT_StatementOfIncomeLocationBalancesAxis=LIXT_ResearchAndDevelopmentExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_TwoVendorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_VendorAndConsultantOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_VendorAndConsultantTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_VendorAndConsultantThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_VendorAndConsultantFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=LIXT_VendorAndConsultantFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |